Cargando…

Sex-specific metabolic functions of adipose Lipocalin-2

OBJECTIVE: Lipocalin-2 (LCN2) is a secreted protein involved in innate immunity and has also been associated with several cardiometabolic traits in both mouse and human studies. However, the causal relationship of LCN2 to these traits is unclear, and most studies have examined only males. METHODS: U...

Descripción completa

Detalles Bibliográficos
Autores principales: Chella Krishnan, Karthickeyan, Sabir, Simon, Shum, Michaël, Meng, Yonghong, Acín-Pérez, Rebeca, Lang, Jennifer M., Floyd, Raquel R., Vergnes, Laurent, Seldin, Marcus M., Fuqua, Brie K., Jayasekera, Dulshan W., Nand, Sereena K., Anum, Diana C., Pan, Calvin, Stiles, Linsey, Péterfy, Miklós, Reue, Karen, Liesa, Marc, Lusis, Aldons J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812340/
https://www.ncbi.nlm.nih.gov/pubmed/31767179
http://dx.doi.org/10.1016/j.molmet.2019.09.009
_version_ 1783462641128177664
author Chella Krishnan, Karthickeyan
Sabir, Simon
Shum, Michaël
Meng, Yonghong
Acín-Pérez, Rebeca
Lang, Jennifer M.
Floyd, Raquel R.
Vergnes, Laurent
Seldin, Marcus M.
Fuqua, Brie K.
Jayasekera, Dulshan W.
Nand, Sereena K.
Anum, Diana C.
Pan, Calvin
Stiles, Linsey
Péterfy, Miklós
Reue, Karen
Liesa, Marc
Lusis, Aldons J.
author_facet Chella Krishnan, Karthickeyan
Sabir, Simon
Shum, Michaël
Meng, Yonghong
Acín-Pérez, Rebeca
Lang, Jennifer M.
Floyd, Raquel R.
Vergnes, Laurent
Seldin, Marcus M.
Fuqua, Brie K.
Jayasekera, Dulshan W.
Nand, Sereena K.
Anum, Diana C.
Pan, Calvin
Stiles, Linsey
Péterfy, Miklós
Reue, Karen
Liesa, Marc
Lusis, Aldons J.
author_sort Chella Krishnan, Karthickeyan
collection PubMed
description OBJECTIVE: Lipocalin-2 (LCN2) is a secreted protein involved in innate immunity and has also been associated with several cardiometabolic traits in both mouse and human studies. However, the causal relationship of LCN2 to these traits is unclear, and most studies have examined only males. METHODS: Using adeno-associated viral vectors we expressed LCN2 in either adipose or liver in a tissue specific manner on the background of a whole-body Lcn2 knockout or wildtype mice. Metabolic phenotypes including body weight, body composition, plasma and liver lipids, glucose homeostasis, insulin resistance, mitochondrial phenotyping, and metabolic cage studies were monitored. RESULTS: We studied the genetics of LCN2 expression and associated clinical traits in both males and females in a panel of 100 inbred strains of mice (HMDP). The natural variation in Lcn2 expression across the HMDP exhibits high heritability, and genetic mapping suggests that it is regulated in part by Lipin1 gene variation. The correlation analyses revealed striking tissue dependent sex differences in obesity, insulin resistance, hepatic steatosis, and dyslipidemia. To understand the causal relationships, we examined the effects of expression of LCN2 selectively in liver or adipose. On a Lcn2-null background, LCN2 expression in white adipose promoted metabolic disturbances in females but not males. It acted in an autocrine/paracrine manner, resulting in mitochondrial dysfunction and an upregulation of inflammatory and fibrotic genes. On the other hand, on a null background, expression of LCN2 in liver had no discernible impact on the traits examined despite increasing the levels of circulating LCN2 more than adipose LCN2 expression. The mechanisms underlying the sex-specific action of LCN2 are unclear, but our results indicate that adipose LCN2 negatively regulates its receptor, LRP2 (or megalin), and its repressor, ERα, in a female-specific manner and that the effects of LCN2 on metabolic traits are mediated in part by LRP2. CONCLUSIONS: Following up on our population-based studies, we demonstrate that LCN2 acts in a highly sex- and tissue-specific manner in mice. Our results have important implications for human studies, emphasizing the importance of sex and the tissue source of LCN2.
format Online
Article
Text
id pubmed-6812340
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68123402019-10-30 Sex-specific metabolic functions of adipose Lipocalin-2 Chella Krishnan, Karthickeyan Sabir, Simon Shum, Michaël Meng, Yonghong Acín-Pérez, Rebeca Lang, Jennifer M. Floyd, Raquel R. Vergnes, Laurent Seldin, Marcus M. Fuqua, Brie K. Jayasekera, Dulshan W. Nand, Sereena K. Anum, Diana C. Pan, Calvin Stiles, Linsey Péterfy, Miklós Reue, Karen Liesa, Marc Lusis, Aldons J. Mol Metab Original Article OBJECTIVE: Lipocalin-2 (LCN2) is a secreted protein involved in innate immunity and has also been associated with several cardiometabolic traits in both mouse and human studies. However, the causal relationship of LCN2 to these traits is unclear, and most studies have examined only males. METHODS: Using adeno-associated viral vectors we expressed LCN2 in either adipose or liver in a tissue specific manner on the background of a whole-body Lcn2 knockout or wildtype mice. Metabolic phenotypes including body weight, body composition, plasma and liver lipids, glucose homeostasis, insulin resistance, mitochondrial phenotyping, and metabolic cage studies were monitored. RESULTS: We studied the genetics of LCN2 expression and associated clinical traits in both males and females in a panel of 100 inbred strains of mice (HMDP). The natural variation in Lcn2 expression across the HMDP exhibits high heritability, and genetic mapping suggests that it is regulated in part by Lipin1 gene variation. The correlation analyses revealed striking tissue dependent sex differences in obesity, insulin resistance, hepatic steatosis, and dyslipidemia. To understand the causal relationships, we examined the effects of expression of LCN2 selectively in liver or adipose. On a Lcn2-null background, LCN2 expression in white adipose promoted metabolic disturbances in females but not males. It acted in an autocrine/paracrine manner, resulting in mitochondrial dysfunction and an upregulation of inflammatory and fibrotic genes. On the other hand, on a null background, expression of LCN2 in liver had no discernible impact on the traits examined despite increasing the levels of circulating LCN2 more than adipose LCN2 expression. The mechanisms underlying the sex-specific action of LCN2 are unclear, but our results indicate that adipose LCN2 negatively regulates its receptor, LRP2 (or megalin), and its repressor, ERα, in a female-specific manner and that the effects of LCN2 on metabolic traits are mediated in part by LRP2. CONCLUSIONS: Following up on our population-based studies, we demonstrate that LCN2 acts in a highly sex- and tissue-specific manner in mice. Our results have important implications for human studies, emphasizing the importance of sex and the tissue source of LCN2. Elsevier 2019-09-27 /pmc/articles/PMC6812340/ /pubmed/31767179 http://dx.doi.org/10.1016/j.molmet.2019.09.009 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Chella Krishnan, Karthickeyan
Sabir, Simon
Shum, Michaël
Meng, Yonghong
Acín-Pérez, Rebeca
Lang, Jennifer M.
Floyd, Raquel R.
Vergnes, Laurent
Seldin, Marcus M.
Fuqua, Brie K.
Jayasekera, Dulshan W.
Nand, Sereena K.
Anum, Diana C.
Pan, Calvin
Stiles, Linsey
Péterfy, Miklós
Reue, Karen
Liesa, Marc
Lusis, Aldons J.
Sex-specific metabolic functions of adipose Lipocalin-2
title Sex-specific metabolic functions of adipose Lipocalin-2
title_full Sex-specific metabolic functions of adipose Lipocalin-2
title_fullStr Sex-specific metabolic functions of adipose Lipocalin-2
title_full_unstemmed Sex-specific metabolic functions of adipose Lipocalin-2
title_short Sex-specific metabolic functions of adipose Lipocalin-2
title_sort sex-specific metabolic functions of adipose lipocalin-2
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812340/
https://www.ncbi.nlm.nih.gov/pubmed/31767179
http://dx.doi.org/10.1016/j.molmet.2019.09.009
work_keys_str_mv AT chellakrishnankarthickeyan sexspecificmetabolicfunctionsofadiposelipocalin2
AT sabirsimon sexspecificmetabolicfunctionsofadiposelipocalin2
AT shummichael sexspecificmetabolicfunctionsofadiposelipocalin2
AT mengyonghong sexspecificmetabolicfunctionsofadiposelipocalin2
AT acinperezrebeca sexspecificmetabolicfunctionsofadiposelipocalin2
AT langjenniferm sexspecificmetabolicfunctionsofadiposelipocalin2
AT floydraquelr sexspecificmetabolicfunctionsofadiposelipocalin2
AT vergneslaurent sexspecificmetabolicfunctionsofadiposelipocalin2
AT seldinmarcusm sexspecificmetabolicfunctionsofadiposelipocalin2
AT fuquabriek sexspecificmetabolicfunctionsofadiposelipocalin2
AT jayasekeradulshanw sexspecificmetabolicfunctionsofadiposelipocalin2
AT nandsereenak sexspecificmetabolicfunctionsofadiposelipocalin2
AT anumdianac sexspecificmetabolicfunctionsofadiposelipocalin2
AT pancalvin sexspecificmetabolicfunctionsofadiposelipocalin2
AT stileslinsey sexspecificmetabolicfunctionsofadiposelipocalin2
AT peterfymiklos sexspecificmetabolicfunctionsofadiposelipocalin2
AT reuekaren sexspecificmetabolicfunctionsofadiposelipocalin2
AT liesamarc sexspecificmetabolicfunctionsofadiposelipocalin2
AT lusisaldonsj sexspecificmetabolicfunctionsofadiposelipocalin2